window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Delivery & Formulation

  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza expands ADC drug product capacity in Switzerland

    Lonza is expanding its commercial-scale aseptic drug product capacity in [...]

    July 23, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development

    Rani reports positive Phase 1 data for oral obesity therapy RT-114

    Rani Therapeutics has reported positive initial Phase 1a data for [...]

    July 16, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation,Research & Development

    EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial

    EpilepsyGTx has partnered with ClearPoint Neuro to support the targeted [...]

    July 14, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Healome raises £2M to advance eye-drop technology for ocular surface diseases

    Healome Therapeutics has raised £2 million in seed funding to [...]

    July 8, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation

    Vect-Horus and Servier partner on targeted oligonucleotide therapies for rare CNS diseases

    Vect-Horus has entered a research collaboration and exclusive licence option [...]

    July 3, 2026
  • Drug Delivery & Formulation

    Lubrizol excipient recognised at CPhI China Pharma Excipients Awards

    Lubrizol’s Apisolex polymer has received a Silver award at the [...]

    June 19, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA grants orphan drug designation to Tris Pharma’s TRN-257 for idiopathic hypersomnia

    FDA has granted orphan drug designation to Tris Pharma’s investigational [...]

    June 11, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development

    Symeres expands spray drying capacity at New Jersey site to support poorly soluble small molecules

    Symeres has expanded spray drying capabilities at its Cranbury site [...]

    June 10, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Genomics and sequencing

    European WiFIX consortium wins €1m Eurostars grant for Nexopore nucleic acid delivery technology

    A European consortium has secured a €1m Eurostars grant to [...]

    June 10, 2026
  • Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics

    Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology

    Glasgow medical technology company Nebu~Flow has secured a £2 million [...]

    June 8, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Natus expands AI-powered EEG analysis across Europe
    Categories: Central Nervous System, Digital & Data, Medical devices
  • Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma
    Categories: Advanced Therapies, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Telix starts Phase 3 trial of radiopharmaceutical therapy for renal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top